Hypoxia induces PTHrP gene transcription in human cancer cells through the HIF-2α

Cell Cycle

Volumn 9, Issue 18, 2010, Pages 3747-3753

  Manisterski, Michal ^a   Golan, Maya ^a   Amir, Sharon ^a   Weisman, Yosef ^a,b   Mabjeesh, Nicola J ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Cancer; HIF 2; Human; Hypoxia; PTHrP

Indexed keywords

2 METHOXYESTRADIOL; COBALT CHLORIDE; DEFEROXAMINE; HYPOXIA INDUCIBLE FACTOR 2ALPHA; PARATHYROID HORMONE RELATED PROTEIN; VASCULOTROPIN;

ARTICLE; CANCER CELL; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYPERCALCEMIA; HYPOXIA; KIDNEY CARCINOMA; MALE; METASTASIS; NEOPLASM; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SECRETION; TRANSCRIPTION INITIATION; TUMOR GROWTH;

EID: 77957008603     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.18.12931     Document Type: Article

References (37)

1. Broadus AE, Mangin M, Ikeda K, Insogna KL, Weir EC, Burtis WJ, et al. Humoral hypercalcemia of cancer. Identification of a novel parathyroid hormone-like peptide. N Engl J Med 1988; 319:556-63.
2. Clines GA, Guise TA. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone. Endocr Relat Cancer 2005; 12:549-83.
3. Nishihara M, Kanematsu T, Taguchi T, Razzaque MS. PTHrP and tumorigenesis: is there a role in prognosis? Ann N Y Acad Sci 2007; 1117:385-92.
4. Deschaseaux F, Sensebe L, Heymann D. Mechanisms of bone repair and regeneration. Trends Mol Med 2009; 15:417-29.
5. Song GJ, Fiaschi-Taesch N, Bisello A. Endogenous parathyroid hormone-related protein regulates the expression of PTH type 1 receptor and proliferation of vascular smooth muscle cells. Mol Endocrinol 2009; 23:1681-90.
6. Neville MC, McFadden TB, Forsyth I. Hormonal regulation of mammary differentiation and milk secretion. J Mammary Gland Biol Neoplasia 2002; 7:49-66. (Pubitemid 38420781)
7. Thomson M, McCarroll J, Bond J, Gordon-Thomson C, E DW, Moore GP. Parathyroid hormone-related peptide modulates signal pathways in skin and hair follicle cells. Exp Dermatol 2003; 12:389-95. (Pubitemid 36992412)
8. Mundy GR, Edwards JR. PTH-related peptide (PTHrP) in hypercalcemia. J Am Soc Nephrol 2008; 19:672-5.
9. Katoh Y, Katoh M. Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation. Curr Mol Med 2009; 9:873-86.
10. Massfelder T, Lang H, Schordan E, Lindner V, Rothhut S, Welsch S, et al. Parathyroid hormone-related protein is an essential growth factor for human clear cell renal carcinoma and a target for the von Hippel-Lindau tumor suppressor gene. Cancer Res 2004; 64:180-8.
11. Kaelin WG Jr. Treatment of kidney cancer: insights provided by the VHL tumor-suppressor protein. Cancer 2009; 115:2262-72.
12. Sourbier C, Massfelder T. Parathyroid hormone-related protein in human renal cell carcinoma. Cancer Lett 2006; 240:170-82. (Pubitemid 44093817)
13. Skuli N, Simon MC. HIF-1alpha versus HIF-2alpha in endothelial cells and vascular functions: is there a master in angiogenesis regulation? Cell Cycle 2009; 8:3252-3.
14. Brahimi-Horn MC, Pouyssegur J. HIF at a glance. J Cell Sci 2009; 122:1055-7.
15. 2 sensing and cancer. Nat Rev Cancer 2008; 8:865-73.
16. Semenza G, Roth P, Fang H, Wang G. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 1994; 269:23757-63. (Pubitemid 24293585)
17. Mabjeesh NJ, Escuin D, LaVallee TM, Pribluda VS, Swartz GM, Johnson MS, et al. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 2003; 3:363-75.
18. Iliopoulos O, Kibel A, Gray S, Kaelin WG Jr. Tumour suppression by the human von Hippel-Lindau gene product. Nat Med 1995; 1:822-6.
19. Kaelin WG Jr. The von Hippel-Lindau tumor suppressor gene and kidney cancer. Clin Cancer Res 2004; 10:6290-5.
20. Xia X, Lemieux ME, Li W, Carroll JS, Brown M, Liu XS, et al. Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis. Proc Natl Acad Sci USA 2009; 106:4260-5.
21. Koudritsky M, Domany E. Positional distribution of human transcription factor binding sites. Nucleic Acids Res 2008; 36:6795-805.
22. Mole DR, Blancher C, Copley RR, Pollard PJ, Gleadle JM, Ragoussis J, et al. Genome-wide association of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha DNA binding with expression profiling of hypoxia-inducible transcripts. J Biol Chem 2009; 284:16767-75.
23. Sellers R, Luchin A, Richard V, Brena R, Lima D, Rosol T. Alternative splicing of parathyroid hormone-related protein mRNA: expression and stability. J Mol Endocrinol 2004; 33:227-41. (Pubitemid 39206359)
24. Lofstedt T, Fredlund E, Holmquist-Mengelbier L, Pietras A, Ovenberger M, Poellinger L, et al. Hypoxia inducible factor-2alpha in cancer. Cell Cycle 2007; 6:919-26.
25. Qing G, Simon MC. Hypoxia inducible factor-2alpha: a critical mediator of aggressive tumor phenotypes. Curr Opin Genet Dev 2009; 19:60-6.
26. Semenza GL. Hypoxia-inducible factor 1 and cancer pathogenesis. IUBMB Life 2008; 60:591-7.
27. Helczynska K, Larsson AM, Holmquist Mengelbier L, Bridges E, Fredlund E, Borgquist S, et al. Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer. Cancer Res 2008; 68:9212-20.
28. Holmquist-Mengelbier L, Fredlund E, Lofstedt T, Noguera R, Navarro S, Nilsson H, et al. Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer Cell 2006; 10:413-23.
29. Luo W, Zhong J, Chang R, Hu H, Pandey A, Semenza GL. Hsp70 and CHIP selectively mediate ubiquitination and degradation of hypoxia-inducible factor (HIF)-1alpha but Not HIF-2alpha. J Biol Chem 285:3651-63.
30. Gilmore JL, Scott JA, Bouizar Z, Robling A, Pitfield SE, Riese DJ, 2nd, et al. Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells. Breast Cancer Res Treat 2008; 110:493-505. (Pubitemid 351962595)
31. Lorch G, Gilmore JL, Koltz PF, Gonterman RM, Laughner R, Lewis DA, et al. Inhibition of epidermal growth factor receptor signalling reduces hypercalcaemia induced by human lung squamous-cell carcinoma in athymic mice. Br J Cancer 2007; 97:183-93.
32. Yamada T, Tsuda M, Ohba Y, Kawaguchi H, Totsuka Y, Shindoh M. PTHrP promotes malignancy of human oral cancer cell downstream of the EGFR signaling. Biochem Biophys Res Commun 2008; 368:575-81.
33. Maeda S, Sutliff RL, Qian J, Lorenz JN, Wang J, Tang H, et al. Targeted overexpression of parathyroid hormone-related protein (PTHrP) to vascular smooth muscle in transgenic mice lowers blood pressure and alters vascular contractility. Endocrinology 1999; 140:1815-25.
34. Abdallah Y, Ross G, Dolf A, Heinemann MP, Schluter KD. N-terminal parathyroid hormone-related peptide hyperpolarizes endothelial cells and causes a reduction of the coronary resistance of the rat heart via endothelial hyperpolarization. Peptides 2006; 27:2927-34. (Pubitemid 44584400)
35. Funk JL, Migliati E, Chen G, Wei H, Wilson J, Downey KJ, et al. Parathyroid hormone-related protein induction in focal stroke: a neuroprotective vascular peptide. Am J Physiol Regul Integr Comp Physiol 2003; 284:1021-30.
36. Amir S, Wang R, Matzkin H, Simons JW, Mabjeesh NJ. MSF-A interacts with hypoxia-inducible factor- 1alpha and augments hypoxia-inducible factor transcriptional activation to affect tumorigenicity and angiogenesis. Cancer Res 2006; 66:856-66. (Pubitemid 43165951)
37. Ben-Shoshan M, Amir S, Dang DT, Dang LH, Weisman Y, Mabjeesh NJ. 1alpha,25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells. Mol Cancer Ther 2007; 6:1433-9. (Pubitemid 46712007)